Aim:
This study aims to investigate the effects of large extracellular vesicles (EVs) induced by pluripotent stem cell-derived mesenchymal stem cells on lower limb ischemic disease and explore its potential mechanisms.
Materials & methods:
The pathology of muscles was accessed by H&E staining and immunofluorescence staining.
In vitro
, we conducted wound-healing assay, tube formation assay, RT qPCR, ELISA, RNA sequencing and proteomic analysis.
Results:
iMSCs-lEVs alleviated the injury of ischemic lower limb and promoted the recovery of lower limb function.
In vitro
, iMSCs-lEVs promoted the proliferation, migration, and angiogenesis of HMEC-1 cells by regulating the ERK/MAPK signing pathway.
Conclusion:
This study demonstrated that iMSCs-lEVs promoted endothelial cell angiogenesis via the ERK/MAPK signaling pathway, thereby improving function after lower limb ischemic injury.